PT - JOURNAL ARTICLE AU - Figueroa-Valverde, Lauro AU - Diaz-Cedillo, Francisco AU - Garcia-Cervera, Elodia AU - Gomez, Eduardo Pool AU - Lopez-Ramos, Maria TI - Effect of progesterone-carbachol derivative on perfusion pressure and coronary resistance in isolated rat heart: via activation of the M<sub>2</sub> muscarinic receptor DP - 2014 Apr 1 TA - Biomedical papers PG - 073--079 VI - 158 IP - 1 AID - 10.5507/bp.2012.010 IS - 12138118 AB - Aim: The present study was designed to investigate the effects of progesterone-carbachol derivative on perfusion pressure and coronary resistance in rats. An additional aim was to identify the molecular mechanisms involved. Methods: The Langendorff model was used to measure perfusion pressure and coronary resistance changes in isolated rat heart after progesterone-carbachol derivative alone and after the following compounds; mifepristone (progesterone receptor blocker), yohimbine (α<sub>2</sub> adreno-receptor antagonist), ICI 118,551 (selective β<sub>2</sub> receptor blocker), atropine (non-selective muscarinic receptor antagonist), methoctramine (antagonist of M<sub>2</sub> receptor) and L-NAME (inhibitor of nitric oxide synthase). Results: The results show that progesterone-carbachol derivative [10<sup>-9</sup> mM] significantly decreased perfusion pressure (P=0.005) and coronary resistance (P=0.006) in isolated rat heart. Additionally, the effect of progesterone-carbachol on perfusion pressure [10<sup>-9</sup> to 10<sup>-4 </sup>mM] was only blocked in the presence of methoctramine and L-NAME. Conclusions: These data suggest that progesterone derivative exert its effect on perfusion pressure via activation of the M<sub>2</sub> muscarinic. In addition, this phenomenon involves stimulation of nitric oxide synthase (NOS).